Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 64

1.

HLA class I and KIR genes do not protect against HIV type 1 infection in highly exposed uninfected individuals with hemophilia A.

Vince N, Bashirova AA, Lied A, Gao X, Dorrell L, McLaren PJ, Fellay J, Carrington M.

J Infect Dis. 2014 Oct 1;210(7):1047-51. doi: 10.1093/infdis/jiu214. Epub 2014 Apr 8.

2.

HLA/KIR restraint of HIV: surviving the fittest.

Bashirova AA, Thomas R, Carrington M.

Annu Rev Immunol. 2011;29:295-317. doi: 10.1146/annurev-immunol-031210-101332. Review.

3.

A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A.

Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J; NIAID Center for HIV/AIDS Vaccine Immunology (CHAVI).

Hum Mol Genet. 2013 May 1;22(9):1903-10. doi: 10.1093/hmg/ddt033. Epub 2013 Jan 30.

4.

Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.

Rallón N, Restrepo C, Vicario JL, Del Romero J, Rodríguez C, García-Samaniego J, García M, Cabello A, Górgolas M, Benito JM.

HIV Med. 2017 Sep;18(8):587-594. doi: 10.1111/hiv.12494. Epub 2017 Feb 20.

5.

KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.

Habegger de Sorrentino A, Sinchi JL, Marinic K, López R, Iliovich E.

Immunology. 2013 Oct;140(2):273-9. doi: 10.1111/imm.12137.

6.

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

Yindom LM, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SM, van der Loeff MS, van Tienen C, Jaye A, Aveika A, Worwui A, Diatta M, Vincent T, Whittle HC, Rowland-Jones SL, Walton R, Carrington M.

J Virol. 2010 Aug;84(16):8202-8. doi: 10.1128/JVI.00116-10. Epub 2010 Jun 2.

7.

Inhibitory KIR/HLA incompatibility between sexual partners confers protection against HIV-1 transmission.

Jennes W, Verheyden S, Mertens JW, Camara M, Seydi M, Dieye TN, Mboup S, Demanet C, Kestens L.

Blood. 2013 Feb 14;121(7):1157-64. doi: 10.1182/blood-2012-09-455352. Epub 2012 Dec 13.

8.

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.

Int J Immunogenet. 2010 Jun;37(3):159-68. doi: 10.1111/j.1744-313X.2010.00906.x. Epub 2010 Feb 24.

PMID:
20193031
9.

Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.

Barbour JD, Sriram U, Caillier SJ, Levy JA, Hecht FM, Oksenberg JR.

PLoS Pathog. 2007 Apr;3(4):e43. Review. No abstract available. Erratum in: PLoS Pathog. 2007 Oct 12;3(10):1540. PLoS Pathog. 2007 Oct;3(10):e154.

10.

Role of HLA, KIR, MICA, and cytokines genes in leprosy.

Jarduli LR, Sell AM, Reis PG, Sippert EÂ, Ayo CM, Mazini PS, Alves HV, Teixeira JJ, Visentainer JE.

Biomed Res Int. 2013;2013:989837. doi: 10.1155/2013/989837. Epub 2013 Jul 8. Review.

11.

KIR2DS3 is associated with protection against acute myeloid leukemia.

Shahsavar F, Tajik N, Entezami KZ, Fallah Radjabzadeh M, Asadifar B, Alimoghaddam K, Ostadali Dahaghi M, Jalali A, Ghashghaie A, Ghavamzadeh A.

Iran J Immunol. 2010 Mar;7(1):8-17. doi: IJIv7i1A2.

12.

Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.

López-Vázquez A, Miña-Blanco A, Martínez-Borra J, Njobvu PD, Suárez-Alvarez B, Blanco-Gelaz MA, González S, Rodrigo L, López-Larrea C.

Hum Immunol. 2005 Mar;66(3):285-9.

PMID:
15784466
13.

HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.

Peterson TA, Kimani J, Wachihi C, Bielawny T, Mendoza L, Thavaneswaran S, Narayansingh MJ, Kariri T, Liang B, Ball TB, Ngugi EN, Plummer FA, Luo M.

Tissue Antigens. 2013 Feb;81(2):93-107. doi: 10.1111/tan.12051.

PMID:
23330720
14.

Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.

Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, Nkengasong JN, Kestens L.

PLoS One. 2011 Feb 14;6(2):e17043. doi: 10.1371/journal.pone.0017043.

15.

Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.

Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.

Tissue Antigens. 2012 Feb;79(2):90-6. doi: 10.1111/j.1399-0039.2011.01812.x. Epub 2011 Nov 30.

PMID:
22128749
16.

Associations of HLA class I antigen specificities and haplotypes with disease progression in HIV-1-infected Hans in Northern China.

Zhang H, Zhao B, Han X, Wang Z, Liu B, Lu C, Zhang M, Liu J, Chen O, Hu Q, Jiang F, Shang H.

Hum Immunol. 2013 Dec;74(12):1636-42. doi: 10.1016/j.humimm.2013.08.287. Epub 2013 Sep 5.

PMID:
24012585
17.

Killer cell immunoglobulin-like receptor (KIR) gene diversity in a population naturally exposed to malaria in Porto Velho, Northern Brazil.

Perce-da-Silva DS, Silva LA, Lima-Junior JC, Cardoso-Oliveira J, Ribeiro-Alves M, Santos F, Porto LC, Oliveira-Ferreira J, Banic DM.

Tissue Antigens. 2015 Mar;85(3):190-9. doi: 10.1111/tan.12523. Epub 2015 Feb 6.

PMID:
25656387
18.

Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.

Tiemessen CT, Paximadis M, Minevich G, Winchester R, Shalekoff S, Gray GE, Sherman GG, Coovadia AH, Kuhn L.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):181-9. doi: 10.1097/QAI.0b013e3182174a76.

19.

Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children.

Singh KK, Qin M, Brummel SS, Angelidou K, Trout RN, Fenton T, Spector SA.

PLoS One. 2016 Mar 16;11(3):e0151364. doi: 10.1371/journal.pone.0151364. eCollection 2016.

20.

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.

Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C.

AIDS. 2015 Mar 13;29(5):507-17. doi: 10.1097/QAD.0000000000000574.

PMID:
25715101

Supplemental Content

Support Center